1. Home
  2. ACHV vs ITIC Comparison

ACHV vs ITIC Comparison

Compare ACHV & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$6.10

Market Cap

618.0M

Sector

Health Care

ML Signal

HOLD

Logo Investors Title Company

ITIC

Investors Title Company

HOLD

Current Price

$282.55

Market Cap

517.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
ITIC
Founded
N/A
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.0M
517.8M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
ACHV
ITIC
Price
$6.10
$282.55
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
2.2M
46.1K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
4.43%
EPS Growth
N/A
13.02
EPS
N/A
3.20
Revenue
N/A
$272,755,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$86.32
Revenue Growth
N/A
5.60
52 Week Low
$2.38
$207.73
52 Week High
$7.11
$291.44

Technical Indicators

Market Signals
Indicator
ACHV
ITIC
Relative Strength Index (RSI) 51.78 60.83
Support Level $4.09 $246.61
Resistance Level $7.11 $286.53
Average True Range (ATR) 0.40 7.07
MACD -0.05 -0.88
Stochastic Oscillator 38.86 69.36

Price Performance

Historical Comparison
ACHV
ITIC

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About ITIC Investors Title Company

Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).

Share on Social Networks: